Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA
- 1 February 2008
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Vaccines
- Vol. 7 (1) , 83-95
- https://doi.org/10.1586/14760584.7.1.83
Abstract
In the year 2000, a heptavalent pneumococcal conjugate vaccine (PCV7) was licensed and recommended for routine immunization of infants in the USA. During the following years, a number of studies documented the impact of this immunization program on rates of invasive pneumococcal disease, pneumonia and otitis media. This article aims to summarize current evidence on the population-based impact of this infant immunization program in the USA.Keywords
This publication has 63 references indexed in Scilit:
- Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?The Lancet Infectious Diseases, 2006
- Clinical features, complications, and outcome in adults with pneumococcal meningitis: a prospective case seriesThe Lancet Neurology, 2006
- Bacterial Meningitis in ChildrenPediatric Clinics of North America, 2005
- Epidemiology and Clinical Characteristics of Community-Acquired Pneumonia in Hospitalized ChildrenPediatrics, 2004
- Pneumococcal meningitis in adults: Spectrum of complications and prognostic factors in a series of 87 casesBrain, 2003
- Estimates of world-wide distribution of child deaths from acute respiratory infectionsPublished by Elsevier ,2002
- Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998Opportunities for Prevention in the Conjugate Vaccine EraJAMA, 2001
- Community acquired pneumonia---a prospective UK studyArchives of Disease in Childhood, 2000
- Outcome of meningitis caused by Streptococcus pneumoniae and Haemophilus influenzae type b in children in The GambiaTropical Medicine & International Health, 2000
- Incidence of Community-Acquired Pneumonia Requiring HospitalizationArchives of internal medicine (1960), 1997